ISB News

In Memory of Bill Bowes, Jr.

“To change the way medicine is done. Cheaper and better. Simple as that.”

That was the reason William Ketcham “Bill” Bowes, Jr., cited when asked why he had supported ISB from the beginning and why he had served on ISB’s board of directors for more than a decade. Bill passed away on Dec. 28, 2016, at the age of 90. The ISB community was especially saddened by the news of his death, because Bill’s presence is so vitally woven into ISB’s fabric. In fact, Bill had met and championed Dr. Lee Hood, who then was at Caltech, 20 years before ISB’s founding. He believed in Lee’s “imaginative inventiveness” and invested in the automated protein sequencing device that Lee had developed. The ISB community is forever grateful for Bill’s vision and generosity. He will always be a part of our history.

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.